Lurasidone Non-Interventional Study in Schizophrenia Patients (NCT06527885) | Clinical Trial Compass
CompletedNot Applicable
Lurasidone Non-Interventional Study in Schizophrenia Patients
Italy61 participantsStarted 2022-10-21
Plain-language summary
The study is a multicentric, national, non-interventional, prospective, single arm study.
The main goal of this study is to gather information about the effects, in a real-life setting, of lurasidone treatment on patient's reported outcomes, in terms of patient's treatment satisfaction, Quality of Life and functioning changes after 6 weeks from lurasidone treatment initiation in schizophrenia patients naïve to lurasidone.
Who can participate
Age range
18 Years – 99 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult (≥18 years) male or female subjects;
* Primary diagnosis of schizophrenia
* Patients not previously treated with lurasidone. The choice to initiate lurasidone treatment is independent of being included in the study;
* Patients legally capable of giving their written consent for participation in the study and for personal data processing.
Exclusion Criteria:
* Concomitant participation in a clinical trial
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Patient's and caregiver's treatment satisfaction- releif of symptoms
Timeframe: 6 weeks after treatment
2
Patient's functioning & quality of life
Timeframe: 6 weeks after treatment
Trial details
NCT IDNCT06527885
SponsorAziende Chimiche Riunite Angelini Francesco S.p.A